Year archive

Opthea Ltd — 2022 filings

All 143 regulatory filings released by Opthea Ltd (OPT) in 2022, sourced directly from the official regulator.

143 Filings

2022 Period

2022 filings (143)

Filing	Released	Lang
Opthea Announces MST Conference call with Jason Slakter MD 2 pages 98.0KB Regulatory Filings	2022-12-12	English
6-K Regulatory Filings	2022-12-12	English
Opthea to present at the FLORetina 2022 Congress 2 pages 130.7KB Investor Presentation	2022-12-06	English
6-K Regulatory Filings	2022-12-06	English
Appendix 2A 21 pages 280.9KB Regulatory Filings	2022-11-29	English
Cleansing Notice 1 page 211.4KB Share Issue/Capital Change	2022-11-29	English
Appendix 3Y MB 3 pages 243.7KB Director's Dealing	2022-11-28	English
Appendix 3Y MS 3 pages 243.1KB Director's Dealing	2022-11-28	English
Cleansing Notice 1 page 211.1KB Share Issue/Capital Change	2022-11-28	English
Appendix 2A 21 pages 281.4KB Regulatory Filings	2022-11-28	English
6-K Regulatory Filings	2022-11-16	English
Chairman's Address to Shareholders 2 pages 175.9KB AGM Information	2022-11-15	English
Results of Meeting 2 pages 339.2KB Declaration of Voting Results & Voting Rights Announcements	2022-11-15	English
Notification regarding unquoted securities - OPT 7 pages 29.6KB Share Issue/Capital Change	2022-11-15	English
Notification regarding unquoted securities - OPT 7 pages 29.4KB Share Issue/Capital Change	2022-11-15	English
Notification regarding unquoted securities - OPT 6 pages 27.8KB Share Issue/Capital Change	2022-11-15	English
6-K Regulatory Filings	2022-11-10	English
Opthea to Present at Jefferies London Healthcare Conference 1 Investor Presentation	2022-11-10	English
Cleansing Notice 1 page 211.1KB Share Issue/Capital Change	2022-10-27	English
Appendix 2A 21 pages 281.0KB Regulatory Filings	2022-10-27	English
Opthea Expands Leadership Team with CFO Appointment 2 pages 211.7KB Board/Management Information	2022-10-24	English
6-K Regulatory Filings	2022-10-24	English
Notice of General Meeting/Proxy Form 110 pages 838.8KB AGM Information	2022-10-16	English
Change in substantial holding 5 pages 1.6MB Major Shareholding Notification	2022-10-04	English
Change in substantial holding 3 pages 92.7KB Major Shareholding Notification	2022-10-04	English
Cleansing Notice 1 page 201.0KB Capital/Financing Update	2022-10-02	English
20-F Annual Report FY 2022	2022-09-29	English
Application for quotation of securities - OPT 5 pages 25.9KB Capital/Financing Update	2022-09-29	English
6-K Regulatory Filings	2022-09-26	English
Completion of Share Purchase Plan 2 pages 156.1KB Capital/Financing Update	2022-09-25	English
Application for quotation of securities - OPT 6 pages 27.5KB Capital/Financing Update	2022-09-25	English
Results of Meeting 2 pages 187.1KB Declaration of Voting Results & Voting Rights Announcements	2022-09-25	English
6-K Regulatory Filings	2022-08-30	English
Opthea Appendix 4E and Annual Report 2022 97 pages 3.3MB Annual Report FY 2022	2022-08-29	English
Opthea reports Fiscal Year 2022 Results and Highlights 2 pages 148.3KB Annual Report FY 2022	2022-08-29	English
Opthea Appendix 4G Corporate Governance Statement 2022 27 pages 762.5KB Regulatory Filings	2022-08-29	English
Change in substantial holding 5 pages 1.6MB Major Shareholding Notification	2022-08-28	English
Change in substantial holding 2 pages 91.8KB Major Shareholding Notification	2022-08-28	English
6-K Regulatory Filings	2022-08-26	English
6-K Regulatory Filings	2022-08-25	English
Cleansing Notice 1 page 214.8KB Capital/Financing Update	2022-08-24	English
Opthea Share Purchase Plan 19 pages 872.7KB Capital/Financing Update	2022-08-24	English
Change in substantial holding 7 pages 217.1KB Major Shareholding Notification	2022-08-24	English
Application for quotation of securities - OPT 5 pages 26.2KB Share Issue/Capital Change	2022-08-23	English
Update - Application for quotation of securities - OPT 5 pages 25.8KB Share Issue/Capital Change	2022-08-23	English
Notice of Extraordinary General Meeting/Proxy Form 15 pages 359.7KB Proxy Solicitation & Information Statement	2022-08-22	English
Opthea to Present at H.C. Wainwright 2nd Annual Conference 1 Investor Presentation	2022-08-16	English
6-K Regulatory Filings	2022-08-15	English
Opthea secures up to US$170m in non-dilutive financing 4 pages 142.2KB Capital/Financing Update	2022-08-14	English
Proposed issue of securities - OPT 5 pages 28.4KB Capital/Financing Update	2022-08-14	English
Proposed issue of securities - OPT 7 pages 31.0KB Capital/Financing Update	2022-08-14	English
Opthea Successfully Closes Well Supported US$90m Financing 4 pages 131.9KB Capital/Financing Update	2022-08-14	English
Form 6-K with SEC 8 pages 145.2KB Capital/Financing Update	2022-08-14	English
Trading Halt 2 pages 282.0KB Regulatory Filings	2022-08-10	English
Notification regarding unquoted securities - OPT 6 pages 28.4KB Share Issue/Capital Change	2022-07-28	English
Notification regarding unquoted securities - OPT 6 pages 28.1KB Share Issue/Capital Change	2022-07-28	English
Notification regarding unquoted securities - OPT 6 pages 28.1KB Share Issue/Capital Change	2022-07-28	English
Ceasing to be a substantial holder 13 pages 387.1KB Major Shareholding Notification	2022-06-21	English
Becoming a substantial holder 42 pages 577.6KB Major Shareholding Notification	2022-06-07	English
Change in substantial holding 2 pages 639.2KB Major Shareholding Notification	2022-06-06	English
Appendix 2A 21 pages 280.3KB Regulatory Filings	2022-05-26	English
Cleansing Notice 1 page 211.0KB Share Issue/Capital Change	2022-05-26	English
Ceasing to be a substantial holder 14 pages 81.8KB Major Shareholding Notification	2022-05-25	English
Change in substantial holding 19 pages 114.0KB Major Shareholding Notification	2022-05-23	English
Change in substantial holding 3 pages 91.3KB Major Shareholding Notification	2022-05-15	English
Opthea To Present at Upcoming Investor Conferences 2 pages 145.6KB Investor Presentation	2022-05-11	English
6-K Regulatory Filings	2022-05-11	English
Opthea Presentation at The Retina World Congress 2022 2 pages 134.8KB Investor Presentation	2022-05-10	English
6-K Regulatory Filings	2022-05-10	English
Opthea Data for OPT-302 for PCV presented at ARVO 2022 2 pages 169.1KB Regulatory Filings	2022-05-05	English
6-K Regulatory Filings	2022-05-05	English
Change in substantial holding 13 pages 284.5KB Major Shareholding Notification	2022-05-02	English
Opthea Presenting Clinical Data at ARVO 2022 Annual Meeting 2 pages 102.9KB Regulatory Filings	2022-05-01	English
6-K Regulatory Filings	2022-04-29	English
Change in substantial holding 15 pages 71.9KB Major Shareholding Notification	2022-04-27	English
Opthea strengthens its Board of Directors 3 pages 121.7KB Board/Management Information	2022-04-25	English
Initial Director's Interest Notice - SO 2 pages 207.6KB Director's Dealing	2022-04-25	English
Initial Director's Interest Notice - QO 2 pages 207.8KB Director's Dealing	2022-04-25	English
Change in substantial holding 14 pages 297.9KB Major Shareholding Notification	2022-04-25	English
6-K Regulatory Filings	2022-04-22	English
6-K Regulatory Filings	2022-04-22	English
6-K Regulatory Filings	2022-04-22	English
Results of Meeting 2 pages 179.1KB Declaration of Voting Results & Voting Rights Announcements	2022-04-20	English
Ceasing to be a substantial holder 10 pages 171.9KB Major Shareholding Notification	2022-04-19	English
Change in substantial holding 15 pages 292.2KB Major Shareholding Notification	2022-04-11	English
Change in substantial holding 15 pages 289.2KB Major Shareholding Notification	2022-04-10	English
6-K Regulatory Filings	2022-03-30	English
Change in substantial holding 13 pages 64.4KB Major Shareholding Notification	2022-03-30	English
Change in substantial holding 14 pages 278.0KB Major Shareholding Notification	2022-03-29	English
Change in substantial holding 20 pages 417.5KB Major Shareholding Notification	2022-03-28	English
Change in substantial holding 24 pages 144.0KB Major Shareholding Notification	2022-03-24	English
Change in substantial holding 19 pages 405.1KB Major Shareholding Notification	2022-03-23	English
Notice of General Meeting and Proxy Form 48 pages 1.3MB Proxy Solicitation & Information Statement	2022-03-14	English
Change in substantial holding 13 pages 63.6KB Major Shareholding Notification	2022-03-14	English
Change in substantial holding 14 pages 283.7KB Major Shareholding Notification	2022-03-13	English
Change in substantial holding 14 pages 279.9KB Major Shareholding Notification	2022-03-13	English
6-K Regulatory Filings	2022-03-10	English
Opthea presents at Oppenheimer's 32nd Healthcare Conference 1 Investor Presentation	2022-03-10	English
Change in substantial holding 14 pages 296.2KB Major Shareholding Notification	2022-03-08	English
Change in substantial holding 3 pages 91.9KB Major Shareholding Notification	2022-03-07	English
6-K Regulatory Filings	2022-03-02	English
Change in substantial holding 17 pages 79.1KB Major Shareholding Notification	2022-03-02	English
Opthea appoints Dr.Joel Naor M.D as Chief Medical Officer 2 pages 118.2KB Board/Management Information	2022-03-02	English
6-K Regulatory Filings	2022-02-28	English
Regulatory Filings 2022 Regulatory Filings	2022-02-28	English
Opthea Half Year Report and Accounts 32 pages 1.2MB Interim / Quarterly Report H1 2022	2022-02-27	English
Regulatory Filings 2022 Regulatory Filings	2022-02-23	English
Change in substantial holding 14 pages 287.5KB Major Shareholding Notification	2022-02-21	English
Change in substantial holding 16 pages 305.5KB Major Shareholding Notification	2022-02-20	English
Becoming a substantial holder 19 pages 229.6KB Major Shareholding Notification	2022-02-17	English
Change in substantial holding 16 pages 303.8KB Major Shareholding Notification	2022-02-15	English
AMENDMENT NO. 2 Major Shareholding Notification	2022-02-14	English
SC 13G/A Major Shareholding Notification	2022-02-14	English
6-K Regulatory Filings	2022-02-14	English
Opthea data for OPT-302 in patients with PVC as presented 3 pages 188.9KB Capital/Financing Update	2022-02-13	English
Angiogenesis 2022 -Prof Cheung presentation of PCV data 20 pages 700.5KB Investor Presentation	2022-02-13	English
6-K Regulatory Filings	2022-02-10	English
Opthea present at SVB Leerink Global Healthcare Conference 1 Investor Presentation	2022-02-10	English
6-K Regulatory Filings	2022-02-09	English
Opthea presents at the Angiogenesis 2022 Conference 1 Investor Presentation	2022-02-09	English
Change in substantial holding 14 pages 279.7KB Major Shareholding Notification	2022-02-08	English
Regulatory Filings 2022 Regulatory Filings	2022-02-07	English
Change in substantial holding 14 pages 281.6KB Major Shareholding Notification	2022-02-06	English
Change in substantial holding 15 pages 298.8KB Major Shareholding Notification	2022-02-03	English
Change in substantial holding 16 pages 304.3KB Major Shareholding Notification	2022-02-02	English
Form F-3 Registration Statement 292 pages 858.4KB Capital/Financing Update	2022-02-01	English
Opthea announces establishment of ATM Equity Program 3 pages 155.3KB Capital/Financing Update	2022-02-01	English
6-K Regulatory Filings	2022-02-01	English
F-3 Regulatory Filings	2022-02-01	English
Becoming a substantial holder 42 pages 573.6KB Major Shareholding Notification	2022-01-30	English
Ceasing to be a substantial holder 14 pages 168.2KB Major Shareholding Notification	2022-01-27	English
Becoming a substantial holder 41 pages 566.2KB Major Shareholding Notification	2022-01-26	English
6-K Regulatory Filings	2022-01-24	English
Opthea Receives A$6.6m R&D Tax Incentive 2 pages 187.8KB Capital/Financing Update	2022-01-24	English
Ceasing to be a substantial holder 14 pages 169.7KB Major Shareholding Notification	2022-01-24	English
Becoming a substantial holder 34 pages 563.9KB Major Shareholding Notification	2022-01-23	English
Change in substantial holding 5 pages 1.1MB Major Shareholding Notification	2022-01-16	English
Ceasing to be a substantial holder 12 pages 54.6KB Major Shareholding Notification	2022-01-16	English
Becoming a substantial holder 36 pages 574.0KB Major Shareholding Notification	2022-01-13	English
FORM 6-K Regulatory Filings	2022-01-04	English
Opthea to present at H.C. Wainwright BIOCONNECT conference 1 Investor Presentation	2022-01-04	English
6-K Regulatory Filings	2022-01-03	English
Opthea appoints CCO to lead Commercialization of OPT-302 2 pages 135.2KB Board/Management Information	2022-01-03	English

Filings by year

2026 5 filings
2025 97 filings
2024 150 filings
2023 108 filings
2022 143 filings
2021 117 filings
2020 100 filings
2019 59 filings
2018 52 filings
2017 49 filings
2016 27 filings
2015 1 filing
2014 46 filings
2013 38 filings
2012 43 filings
2011 47 filings
2010 42 filings
2009 38 filings
2008 56 filings
2007 34 filings
2006 29 filings
2005 20 filings
2004 27 filings
2003 57 filings
2002 5 filings